Title:
【発明の名称】アドレナリン性化合物
Document Type and Number:
Japanese Patent JPH0635444
Kind Code:
B2
Abstract:
Disclosed herein are adrenergic compounds represented by the formula wherein m is 0, 1 or 2; R1, R2, R3 are taken from the group consisting of hydrogen, hydroxy, loweralkyl, loweralkoxy, halo, or NHSO2R wherein R is taken from the group consisting of hydrogen, loweralkyl or arylalkyl, provided that R1, R2, R3 cannot simultaneously be hydrogen, and provided that when one of R1, R2, R3 is halo, the other two cannot simultaneously be hydrogen; R1 and R2 or R2 and R3 taken together can form a methylenedioxy or ethylenedioxy bridge; and R4 and R5 are hydrogen or taken together form a closed ring of the formula wherein n is 1 or 2, and the dashed line represents a single or double bond when n is 1, and R6 is taken from the group consisting of hydrogen, loweralkyl, or arylalkyl, and the pharmaceutically acceptable salts thereof.
More Like This:
| JP4870570 | N-acylsulfonamide-based apoptosis promoter |
| WO/2009/096526 | CARBOXYLIC ACID COMPOUND OR SALT THEREOF |
| JP2005500297 | Imidazole derivative that regulates sodium channel |
Inventors:
JON FURANSHISU DEBERUNAAJISU
FUACHIMA ZERA BESA
FUACHIMA ZERA BESA
Application Number:
JP12162085A
Publication Date:
May 11, 1994
Filing Date:
June 06, 1985
Export Citation:
Assignee:
ABBOTT LAB
International Classes:
C07D233/06; A61K31/155; A61K31/18; A61K31/357; A61K31/36; A61K31/415; A61K31/505; A61P3/04; A61P9/12; A61P25/02; A61P25/04; A61P25/06; A61P25/24; A61P25/26; C07C67/00; C07C239/00; C07C257/16; C07D233/10; C07D233/14; C07D233/22; C07D239/06; C07D239/26; C07D317/70; C07D405/04; (IPC1-7): C07D233/10; A61K31/415; A61K31/505; C07D233/14; C07D239/26; C07D405/04
Domestic Patent References:
| JP59139361A |
Attorney, Agent or Firm:
Takehiko Saito (1 outside)
Next Patent: MEMORY ACCESS TIME CONTROL SYSTEM